title: Iatrogenic hypercalcemia in hemodialysis patients in spite of the use of low dialysate calcium.
authors.forename: M
authors.initials: M
authors.lastname: Goicoechea
authors.forename: N
authors.initials: N
authors.lastname: Pascual
authors.forename: M
authors.initials: M
authors.lastname: Zaleski
authors.forename: C
authors.initials: C
authors.lastname: Andrea
authors.forename: J
authors.initials: J
authors.lastname: Hernández
authors.forename: P
authors.initials: P
authors.lastname: de Sequera
mesh_terms: D000284:Administration, Oral; D002117:Calcitriol / Q000008:administration & dosage / Q000009:adverse effects; D002118:Calcium / Q000008:administration & dosage*; D002119:Calcium Carbonate / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D015312:Hemodialysis Solutions / Q000737:chemistry*; D006801:Humans; D006934:Hypercalcemia / Q000453:epidemiology / Q000209:etiology*; D007049:Iatrogenic Disease; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D015312:Hemodialysis Solutions; D002117:Calcitriol; D002119:Calcium Carbonate; D002118:Calcium